Morgan Stanley Maintains Equal-Weight on Ovintiv, Raises Price Target to $71
Benzinga Newsdesk 2 weeks ago
Analyst RatingsNewsPrice Target
Morgan Stanley analyst Devin McDermott maintains Ovintiv (NYSE:OVV) with a Equal-Weight and raises the price target from $67 to $71.
Morgan Stanley analyst Devin McDermott maintains Ovintiv (NYSE:OVV) with a Equal-Weight and raises the price target from $67 to $71.